Ocular Therapeutix, Inc.OCUL stock score: 38/100

$5.86 · -1.35% · Scored Nov 19, 2026

Technical
24
Fundamental
42
News
—

The reading

Ocular Therapeutix (OCUL) scores 38 out of 100, which reads bearish, higher than 18% of Healthcare stocks and 19% of the 4,118 US stocks we score.

The composite weights fundamentals 80% and technicals 20%: fundamentals read 42, technicals 24.

Among the fundamentals, Quick Ratio at 100 and Price Target at 100 score highest, while Earnings Profitability (Quarterly) at 0 weighs the most against it.

On the daily chart, trend-following indicators average 15 and contrarian oscillators 66 — a split worth reading before trusting the technical total.

Since Aug 22, 2026 the composite has ranged from 31 to 51, and it is down 12 points over the period.

About Ocular Therapeutix

Ocular Therapeutix (OCUL) is a biopharmaceutical company based in Bedford, Massachusetts, that develops eye treatments using a bioresorbable hydrogel that releases drugs slowly over time. Its lead candidate, AXPAXLI, is an implant injected into the eye that releases axitinib, a drug that blocks blood vessel growth, and it is designed to treat wet age-related macular degeneration with far fewer injections than current therapies. AXPAXLI met its main goal in a late-stage trial against aflibercept, a widely used treatment, and a second late-stage trial is under way, with the company pursuing U.S. approval. Ocular already sells DEXTENZA, a dexamethasone insert placed in the tear duct to treat inflammation and pain after eye surgery and itching from allergic conjunctivitis, which provides its current product revenue.

In wet AMD, Ocular competes with Regeneron’s Eylea, Roche’s Vabysmo and Susvimo, and Novartis, as well as with EyePoint Pharmaceuticals, which is developing another long-acting implant. Its edge rests on an implant that may extend time between treatments to many months and on hydrogel technology already used in an approved product. Investors who follow OCUL stock tend to watch data from the second AXPAXLI late-stage trial and progress toward a marketing application. Safety findings and the regulatory path are closely followed. DEXTENZA sales, cash runway and commercial preparations are other factors.

What’s driving the score

The strongest and weakest of the scorers that count toward OCUL’s composite. Each returns 0–100, higher is more bullish — including metrics where low is good, like P/E.

Fundamental

42

Pulling it up

  • Quick ratio measures a company's ability to meet short-term obligations with liquid assets.

  • Price target score compares the current stock price to analyst consensus targets.

  • Current assets divided by current liabilities: the ability to pay short-term bills.

Holding it back

  • Earnings Profitability (Quarterly) measures recent profitability using trailing 12-month quarterly data.

  • How reliably yearly earnings grow: the share of years with higher earnings, the compound growth rate, how steady that growth is, and the last two yearly changes.

  • Absolute profitability: whether the company is profitable, its net margin against the sector range, and how consistently it has been profitable over three years.

38 weighted scorers; 1 had no data today and are left out rather than counted as zero.

Technical · daily

20

Pulling it up

  • Bollinger Bands (20-period) plot standard deviations above and below a moving average.

  • Money Flow Index (14-period) is a volume-weighted RSI that identifies overbought and oversold conditions.

  • Relative Strength Index (14-period) measures momentum by comparing recent gains to losses.

Holding it back

  • S&P 500 52-week comparison evaluates the stock's annual performance relative to the broader market.

  • Candlestick patterns recognize specific price formations that historically suggest continuation or reversal.

  • Where the price sits between its 52-week low and high.

62 weighted scorers; 3 had no data today and are left out rather than counted as zero.

Technical score by timeframe

ChartScoreWeight
Hourly381
Daily203
Weekly182
Monthly292

Composite score, last 90 days

05010038Aug 22, 2026Nov 19, 2026Aug 22, 2026: 50Aug 23, 2026: 50Aug 24, 2026: 49Aug 25, 2026: 49Aug 26, 2026: 50Aug 27, 2026: 49Aug 28, 2026: 48Aug 29, 2026: 47Aug 30, 2026: 48Aug 31, 2026: 48Sep 1, 2026: 49Sep 2, 2026: 50Sep 3, 2026: 50Sep 4, 2026: 48Sep 5, 2026: 49Sep 6, 2026: 49Sep 7, 2026: 49Sep 8, 2026: 51Sep 9, 2026: 51Sep 10, 2026: 49Sep 11, 2026: 47Sep 12, 2026: 48Sep 13, 2026: 48Sep 14, 2026: 48Sep 15, 2026: 46Sep 16, 2026: 44Sep 17, 2026: 47Sep 18, 2026: 45Sep 19, 2026: 46Sep 20, 2026: 46Sep 21, 2026: 45Sep 22, 2026: 49Sep 23, 2026: 48Sep 24, 2026: 46Sep 25, 2026: 42Sep 26, 2026: 42Sep 27, 2026: 42Sep 28, 2026: 35Sep 29, 2026: 35Sep 30, 2026: 34Oct 1, 2026: 32Oct 2, 2026: 32Oct 3, 2026: 32Oct 4, 2026: 32Oct 5, 2026: 33Oct 6, 2026: 34Oct 7, 2026: 33Oct 8, 2026: 34Oct 9, 2026: 35Oct 10, 2026: 35Oct 11, 2026: 35Oct 12, 2026: 35Oct 13, 2026: 34Oct 14, 2026: 34Oct 15, 2026: 33Oct 16, 2026: 32Oct 17, 2026: 32Oct 18, 2026: 32Oct 19, 2026: 31Oct 20, 2026: 32Oct 21, 2026: 32Oct 22, 2026: 32Oct 23, 2026: 32Oct 24, 2026: 31Oct 25, 2026: 32Oct 26, 2026: 32Oct 27, 2026: 34Oct 28, 2026: 35Oct 29, 2026: 36Oct 30, 2026: 34Nov 1, 2026: 35Nov 2, 2026: 32Nov 3, 2026: 33Nov 4, 2026: 36Nov 5, 2026: 32Nov 6, 2026: 32Nov 7, 2026: 32Nov 8, 2026: 32Nov 10, 2026: 32Nov 11, 2026: 33Nov 12, 2026: 36Nov 13, 2026: 38Nov 14, 2026: 38Nov 15, 2026: 38Nov 16, 2026: 38Nov 17, 2026: 38Nov 18, 2026: 38Nov 19, 2026: 38
Show the daily numbers
DateComposite
Nov 19, 202638
Nov 18, 202638
Nov 17, 202638
Nov 16, 202638
Nov 15, 202638
Nov 14, 202638
Nov 13, 202638
Nov 12, 202636
Nov 11, 202633
Nov 10, 202632
Nov 8, 202632
Nov 7, 202632
Nov 6, 202632
Nov 5, 202632
Nov 4, 202636
Nov 3, 202633
Nov 2, 202632
Nov 1, 202635
Oct 30, 202634
Oct 29, 202636
Oct 28, 202635
Oct 27, 202634
Oct 26, 202632
Oct 25, 202632
Oct 24, 202631
Oct 23, 202632
Oct 22, 202632
Oct 21, 202632
Oct 20, 202632
Oct 19, 202631
Oct 18, 202632
Oct 17, 202632
Oct 16, 202632
Oct 15, 202633
Oct 14, 202634
Oct 13, 202634
Oct 12, 202635
Oct 11, 202635
Oct 10, 202635
Oct 9, 202635
Oct 8, 202634
Oct 7, 202633
Oct 6, 202634
Oct 5, 202633
Oct 4, 202632
Oct 3, 202632
Oct 2, 202632
Oct 1, 202632
Sep 30, 202634
Sep 29, 202635
Sep 28, 202635
Sep 27, 202642
Sep 26, 202642
Sep 25, 202642
Sep 24, 202646
Sep 23, 202648
Sep 22, 202649
Sep 21, 202645
Sep 20, 202646
Sep 19, 202646
Sep 18, 202645
Sep 17, 202647
Sep 16, 202644
Sep 15, 202646
Sep 14, 202648
Sep 13, 202648
Sep 12, 202648
Sep 11, 202647
Sep 10, 202649
Sep 9, 202651
Sep 8, 202651
Sep 7, 202649
Sep 6, 202649
Sep 5, 202649
Sep 4, 202648
Sep 3, 202650
Sep 2, 202650
Sep 1, 202649
Aug 31, 202648
Aug 30, 202648
Aug 29, 202647
Aug 28, 202648
Aug 27, 202649
Aug 26, 202650
Aug 25, 202649
Aug 24, 202649
Aug 23, 202650
Aug 22, 202650

Key facts

Market cap
$1.3B
Sector
Healthcare
Industry
Biotechnology
Beta
1.22
Risk grade (1–10)
9
Next earnings
Feb 4, 2027

Questions

What is OCUL's stock rating today?

OCUL scores 38/100 (Bearish) as of Nov 19, 2026: technical 24, fundamental 42. Scores are recomputed every night.

What does Ocular Therapeutix do?

Ocular Therapeutix (OCUL) is a biopharmaceutical company based in Bedford, Massachusetts, that develops eye treatments using a bioresorbable hydrogel that releases drugs slowly over time. Its lead candidate, AXPAXLI, is an implant injected into the eye that releases axitinib, a drug that blocks blood vessel growth, and it is designed to treat wet age-related macular degeneration with far fewer injections than current therapies.

Is OCUL stock a buy?

The score is not a buy or sell recommendation. A 38 says the technical and fundamental signals we measure lean bearish today, relative to every other stock scored the same way. Use the breakdown above to see why, and treat it as a starting point for your own research.

How is the OCUL score calculated?

100 weighted scorers feed it today: 38 fundamental, scored against Healthcare ranges, and 62 technical on the daily chart, with 4 timeframes blended into the technical total. Every scorer returns 0–100; missing data is left out, never counted as zero.

Scores are information, not investment advice. Computed from Yahoo Finance, Finnhub and Alpha Vantage data; technical indicators via TA-Lib. Past scores do not predict future returns.

Embed this score

A badge for a blog post, newsletter or README. It updates every night and links back here. More badges

OCUL stock score

HTML

<a href="https://stocksscores.com/stocks/ocul/"><img src="https://stocksscores.com/stocks/ocul/badge.svg" alt="OCUL stock score" height="20"></a>

Markdown

[![OCUL stock score](https://stocksscores.com/stocks/ocul/badge.svg)](https://stocksscores.com/stocks/ocul/)